Figure 1From: Tocotrienols are good adjuvants for developing cancer vaccines (a) DCs stained with CD11c monoclonal antibody, i) untreated DC was stained with CD11c compared with unstained DC. ii) Stained DC treated with 8 μg/ml of TRF compared with unstained DC. (b) DCs stained with CD86, i) untreated DC. ii) DC treated with 8 μg/ml of TRF. (c) DCs stained with MHC class II, (i) untreated DC. ii) DC treated with 8 μg/ml of TRF.Back to article page